The Danish severe asthma register: an electronic platform for severe asthma management and research
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The Danish severe asthma register : an electronic platform for severe asthma management and research. / Hansen, Susanne; Hilberg, Ole; Ulrik, Charlotte Suppli; Bodtger, Uffe; M. Rasmussen, Linda; D. Assing, Karin; Wimmer-Aune, Alexandra; B. Rasmussen, Kirsten; Bjerring, Niels; Christiansen, Anders; Schmid, Johannes; Krogh, Niels Steen; Porsbjerg, Celeste.
I: European Clinical Respiratory Journal, Bind 8, Nr. 1, 1842117, 2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The Danish severe asthma register
T2 - an electronic platform for severe asthma management and research
AU - Hansen, Susanne
AU - Hilberg, Ole
AU - Ulrik, Charlotte Suppli
AU - Bodtger, Uffe
AU - M. Rasmussen, Linda
AU - D. Assing, Karin
AU - Wimmer-Aune, Alexandra
AU - B. Rasmussen, Kirsten
AU - Bjerring, Niels
AU - Christiansen, Anders
AU - Schmid, Johannes
AU - Krogh, Niels Steen
AU - Porsbjerg, Celeste
PY - 2021
Y1 - 2021
N2 - The evaluation and management of severe asthma patients require collection of comprehensive information, which is often a challenge in a busy outpatient clinic. The Danish Severe Asthma Register (DSAR) was designed as an electronic patient record form that captures operational clinical data and provides a clinical overview of the severe asthma patient. DSAR is a nationwide register; all patients in Denmark who are treated with biologics for severe asthma are included, and data are as a minimum entered at start of biological treatment, after four and 12 months of treatment, and hereafter annually. Currently, there are data from 621 treatment courses with biologics included in DSAR, with 71% of patients treated with anti-IL-5 drugs and 29% with an anti-IgE drug. Patients enter Patient Reported Outcome Measures electronically on tablets when they arrive in the outpatient clinic and their answers are immediately available to the clinician during the consultation. Nurses and doctors enter clinical data into DSAR during the consultation. DSAR offers immediate access to well-presented longitudinal overview and automatically creates a journal output that can be copy-pasted into the hospital’s existing health record form. DSAR is also currently expanding with an app, to be used for monitoring of home-treatment. In addition to serving as an electronic patient record form, DSAR will also provide opportunities to monitor the real-life efficacy of biological treatment for severe asthma in Denmark, and it will be a valuable research platform that will aid in answering important research questions on severe asthma in the future.
AB - The evaluation and management of severe asthma patients require collection of comprehensive information, which is often a challenge in a busy outpatient clinic. The Danish Severe Asthma Register (DSAR) was designed as an electronic patient record form that captures operational clinical data and provides a clinical overview of the severe asthma patient. DSAR is a nationwide register; all patients in Denmark who are treated with biologics for severe asthma are included, and data are as a minimum entered at start of biological treatment, after four and 12 months of treatment, and hereafter annually. Currently, there are data from 621 treatment courses with biologics included in DSAR, with 71% of patients treated with anti-IL-5 drugs and 29% with an anti-IgE drug. Patients enter Patient Reported Outcome Measures electronically on tablets when they arrive in the outpatient clinic and their answers are immediately available to the clinician during the consultation. Nurses and doctors enter clinical data into DSAR during the consultation. DSAR offers immediate access to well-presented longitudinal overview and automatically creates a journal output that can be copy-pasted into the hospital’s existing health record form. DSAR is also currently expanding with an app, to be used for monitoring of home-treatment. In addition to serving as an electronic patient record form, DSAR will also provide opportunities to monitor the real-life efficacy of biological treatment for severe asthma in Denmark, and it will be a valuable research platform that will aid in answering important research questions on severe asthma in the future.
KW - biological treatment
KW - clinical decision-making tool
KW - electronic patient record
KW - real-life efficacy
KW - Severe asthma
KW - severe asthma research
U2 - 10.1080/20018525.2020.1842117
DO - 10.1080/20018525.2020.1842117
M3 - Journal article
C2 - 33209214
AN - SCOPUS:85094957077
VL - 8
JO - European Clinical Respiratory Journal
JF - European Clinical Respiratory Journal
SN - 2001-8525
IS - 1
M1 - 1842117
ER -
ID: 255110460